Abstract
The aim of this study was to test the feasibility and utility of developing patient-derived orthotopic xenograft (PDOX) models for patients with malignant peripheral nerve sheath tumors (MPNSTs) to aid therapeutic interventions in real time. A sporadic relapsed MPNST developed in a 14-year-old boy was engrafted in mice, generating a PDOX model for use in co-clinical trials after informed consent. SNP-array and exome sequencing was performed on the relapsed tumor. Genomics, drug availability, and published literature guided PDOX treatments. A MPNST PDOX model was generated and expanded. Analysis of the patient's relapsed tumor revealed mutations in the MAPK1, EED, and CDK2NA/B genes. First, the PDOX model was treated with the same therapeutic regimen as received by the patient (everolimus and trametinib); after observing partial response, tumors were left to regrow. Regrown tumors were treated based on mutations (palbociclib and JQ1), drug availability, and published literature (nab-paclitaxel; bevacizumab; sorafenib plus doxorubicin; and gemcitabine plus docetaxel). The patient had a lung metastatic relapse and was treated according to PDOX results, first with nab-paclitaxel, second with sorafenib plus doxorubicin after progres...Continue Reading
References
Aug 15, 2003·Surgical Oncology Clinics of North America·Courtney L Scaife, Peter W Pisters
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Modesto CarliJoern Treuner
Sep 4, 2007·The Oncologist·Robert G Maki
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Dec 15, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrea FerrariSheri L Spunt
Aug 24, 2011·Annals of Surgical Oncology·Chee-Chee H StuckyNabil Wasif
Aug 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·August VidalAlberto Villanueva
Dec 12, 2012·The Journal of Clinical Investigation·Walter J JessenNancy Ratner
Apr 1, 2014·Oncotarget·Adrienne L WatsonDavid A Largaespada
Aug 15, 2014·Nature·Thomas De RaedtKaren Cichowski
Sep 14, 2014·Cancer Research·Chiara AmbrogioAlberto Villanueva
Sep 23, 2014·Nature Genetics·William LeePing Chi
Mar 27, 2015·EMBO Molecular Medicine·Joan CastellsaguéConxi Lázaro
Jul 15, 2015·Molecular and Clinical Oncology·Amir SonnenblickDaniela Katz
Nov 4, 2015·Oncotarget·Marco PerezAmancio Carnero
Mar 29, 2016·Sarcoma·Gaetano ApiceFrancesco Perrone
Oct 26, 2016·Oncotarget·Michael S LeeScott Kopetz
Dec 29, 2016·The New England Journal of Medicine·Eva DombiBrigitte C Widemann
Jan 27, 2017·Genes, Chromosomes & Cancer·Pierre SohierMeena Upadhyaya
Jun 3, 2017·Bioinformatics·Bernat Gel, Eduard Serra
Jun 9, 2017·Sarcoma·AeRang KimBrigitte C Widemann
Aug 17, 2017·PloS One·Azadeh AmirnasrErik A C Wiemer
Sep 2, 2017·Experimental Neurology·AeRang Kim, Christine A Pratilas
Sep 25, 2017·Cell·Jean-David Rochaix
Nov 9, 2017·Journal of the National Cancer Institute·Karlyne M ReillyDouglas R Stewart
Nov 10, 2017·Scientific Reports·Andrew S BrohlDamon R Reed
Mar 8, 2018·Oncogene·Sara BolinFredrik J Swartling
Jul 18, 2018·Nature Methods·Sangtae KimChristopher T Saunders
Aug 22, 2018·International Journal of Molecular Sciences·Cristian P MoiolaEva Colas